-

Exactech Announces Preferred Relationship with Permedica S.p.A. in Spain

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement is proud to announce a preferred relationship with Permedica S.p.A. to distribute hip replacement products in Spain.

The portfolio complements Exactech’s existing portfolio in Spain by adding Permedica’s novel, 3D-printed cup, extensive liner options including ceramic, vitamin E cross-linked and dual mobility, as well as a wide range of stem options.

“The addition of these products strengthens our position in the Spanish market by providing us access to a complete European hip portfolio. I look forward to the opportunity to serve more patients with these complementary implants,” said Nicolas Hohl, director of sales and market development for EMEA at Exactech.

“This partnership enhances our national Spanish position in the recon business, providing significant opportunities for both Exactech and Permedica to grow together in the coming years,” said Permedica Sales Manager Federico Perego. “Moreover, the goal of this important agreement is to promote quality products and build solid bases to further spread innovative solutions that can help more patients.”

The innovative TRASER® technology creates implants with the Selective Laser Melting additive technology, printing them layer by layer, using Ti6Al4V powder.

“Initial and long-term fixation and osseointegration are key to restoring hip joint function,” said Dr C. Esteve Balzola, chief of the orthopedic and traumatology department of the Hospital del Vendrell in Tarragona, who was among the first to use the product in the country. “The Jump Cup Traser technology helps achieve this objective and provides intraoperative flexibility with various options in friction couples and the possibility of dual mobility.”

About Exactech

Exactech is a global medical device company that develops and markets orthopaedic implant devices, related surgical instruments and the Active Intelligence® platform of smart technologies to hospitals and physicians. Headquartered in Gainesville, Fla., Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Visit www.exac.com for more information and connect with us on LinkedIn, Vumedi, YouTube, Instagram and Twitter.

Contacts

Morgan Lee, Exactech Marketing Communications
Morgan.lee@exac.com

Exactech

Details
Headquarters: Gainesville, Fla.
Website: www.exac.com
CEO: Darin Johnson
Employees: 800
Organization: PRI


Contacts

Morgan Lee, Exactech Marketing Communications
Morgan.lee@exac.com

More News From Exactech

Exactech Announces FDA 510(k) Clearance of the World’s First Surgical Navigation for Total Ankle Replacement

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, announced its subsidiary, BlueOrtho, has received 510(k) clearance from the Food and Drug Administration for ExactechGPS® Ankle, the world’s first surgical navigation system for total ankle arthroplasty (TAA). GPS Ankle is a first-of-its-kind technology, which connects the preoperative plan with real-time intraoperative instrument g...

Exactech Publishes New Machine Learning Research That Evaluates Fairness and Accuracy of AI Predictions

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, reports a new study1 that demonstrates its machine learning clinical decision support tool, Predict+™, creates fair and accurate outcomes predictions for shoulder arthroplasty patients of different ethnicity, sex and age. The study, the first of its kind in orthopaedics, has just been published in the Journal of Shoulder and Elbow...

Exactech AI Platform Surpasses 100,000 Joint Replacement Surgeries Worldwide

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced today its Active Intelligence® (AI) platform surpassed more than 100,000 total joint replacement surgeries across the globe. “We are proud to reach this incredible milestone of more than 100,000 patients with the support of our surgeon partners worldwide,” said Exactech CEO Darin Johnson. “As a leader in orthopaedic innov...
Back to Newsroom